Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 43Carcinoma, Non-Small-Cell Lung 35Breast Neoplasms 35Triple Negative Breast Neoplasms 16Neoplasms 15Neoplasm Metastasis 14Carcinoma 9Adenocarcinoma 9Lung Neoplasms 7Head and Neck Neoplasms 6Colorectal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Pancreatic Diseases 5Cholangiocarcinoma 5Carcinoma, Squamous Cell 5Neoplasms by Site 4Melanoma 4Digestive System Neoplasms 4Digestive System Diseases 4Sarcoma 3Pancreatic Adenocarcinoma 3Neoplasms by Histologic Type 3Inflammatory Breast Neoplasms 3Endocrine System Diseases 3Endocrine Gland Neoplasms 3Carcinoma, Pancreatic Ductal 3Carcinoma, Ovarian Epithelial 3Uveal Melanoma 2Urinary Bladder Neoplasms 2

Interventions

Gemcitabine 2irinotecan sucrosofate 1cabiralizumab 1Oxaliplatin 1Nivolumab 1Leucovorin 1Irinotecan 1IMM-101 1Fluorouracil 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Pancreatic Cancer × 130-nm albumin-bound paclitaxel × Clear all
NCT03336216 2024-07-23

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Bristol-Myers Squibb

Phase 2 Completed
205 enrolled 30 charts
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡